The use of blood levels of antiepileptic drugs in clinical practice.
D000284:Administration, Oral; D000328:Adult; D000927:Anticonvulsants / Q000097:blood*; D001702:Biopharmaceutics; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D002648:Child; D004361:Drug Tolerance; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy; D005013:Ethosuximide / Q000009:adverse effects / Q000097:blood; D006801:Humans; D007273:Injections, Intramuscular; D009759:Nystagmus, Pathologic / Q000139:chemically induced; D010634:Phenobarbital / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D011324:Primidone / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000927:Anticonvulsants; D011324:Primidone; D002220:Carbamazepine; D005013:Ethosuximide; D010672:Phenytoin; D010634:Phenobarbital